ProfileGDS5678 / 1442307_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 6% 6% 6% 7% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.144466
GSM967853U87-EV human glioblastoma xenograft - Control 22.11566
GSM967854U87-EV human glioblastoma xenograft - Control 32.126786
GSM967855U87-EV human glioblastoma xenograft - Control 42.119867
GSM967856U87-EV human glioblastoma xenograft - Control 52.084196
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.164476
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.142546
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.102296
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.097776
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.112396
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.112396
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.090646
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.114386
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.114426